These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28118838)

  • 21. Cost-effectiveness of metformin plus vildagliptin compared with metformin plus sulphonylurea for the treatment of patients with type 2 diabetes mellitus: a Portuguese healthcare system perspective.
    Viriato D; Calado F; Gruenberger JB; Ong SH; Carvalho D; Silva-Nunes J; Johal S; Viana R
    J Med Econ; 2014 Jul; 17(7):499-507. PubMed ID: 24708176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HypoAware-a brief and partly web-based psycho-educational group intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycaemia: design of a cost-effectiveness randomised controlled trial.
    Rondags SM; de Wit M; van Tulder MW; Diamant M; Snoek FJ
    BMC Endocr Disord; 2015 Aug; 15():43. PubMed ID: 26292674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of comorbid depression on quality of life in adults with Type 2 diabetes.
    Egede LE; Hernández-Tejada MA
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):83-91. PubMed ID: 23402449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An economic evaluation of an abdominal aortic aneurysm screening program in Italy.
    Giardina S; Pane B; Spinella G; Cafueri G; Corbo M; Brasseur P; Orengo G; Palombo D
    J Vasc Surg; 2011 Oct; 54(4):938-46. PubMed ID: 21820837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
    Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
    Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece.
    Gourzoulidis G; Tzanetakos C; Ioannidis I; Tsapas A; Kourlaba G; Papageorgiou G; Maniadakis N
    Clin Drug Investig; 2018 May; 38(5):417-426. PubMed ID: 29349708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of insulin degludec compared with insulin glargine for patients with type 2 diabetes treated with basal insulin - from the UK health care cost perspective.
    Evans M; Wolden M; Gundgaard J; Chubb B; Christensen T
    Diabetes Obes Metab; 2014 Apr; 16(4):366-75. PubMed ID: 24373113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-utility analysis of liraglutide versus glimepiride as add-on to metformin in type 2 diabetes patients in China.
    Gao L; Zhao FL; Li SC
    Int J Technol Assess Health Care; 2012 Oct; 28(4):436-44. PubMed ID: 23006540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost effectiveness of preventive screening programmes for type 2 diabetes mellitus in Germany.
    Schaufler TM; Wolff M
    Appl Health Econ Health Policy; 2010; 8(3):191-202. PubMed ID: 20408603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Foos V; Lurati FM; Lammert M; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S5-26. PubMed ID: 15324513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The economics of screening and treatment in type 2 diabetes mellitus.
    Raikou M; McGuire A
    Pharmacoeconomics; 2003; 21(8):543-64. PubMed ID: 12751913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
    Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
    Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving quality of care in people with Type 2 diabetes through the Associazione Medici Diabetologi-annals initiative: a long-term cost-effectiveness analysis.
    Giorda CB; Nicolucci A; Pellegrini F; Kristiansen CK; Hunt B; Valentine WJ; Vespasiani G
    Diabet Med; 2014 May; 31(5):615-23. PubMed ID: 24246087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incremental Cost-Effectiveness Analysis of Gestational Diabetes Mellitus Screening Strategies in Singapore.
    Chen PY; Finkelstein EA; Ng MJ; Yap F; Yeo GS; Rajadurai VS; Chong YS; Gluckman PD; Saw SM; Kwek KY; Tan KH
    Asia Pac J Public Health; 2016 Jan; 28(1):15-25. PubMed ID: 26512030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of population-based, community, workplace and individual policies for diabetes prevention in the UK.
    Breeze PR; Thomas C; Squires H; Brennan A; Greaves C; Diggle P; Brunner E; Tabak A; Preston L; Chilcott J
    Diabet Med; 2017 Aug; 34(8):1136-1144. PubMed ID: 28294392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing.
    GoodSmith MS; Skandari MR; Huang ES; Naylor RN
    Diabetes Care; 2019 Dec; 42(12):2247-2255. PubMed ID: 31558549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost-effectiveness of intensive therapy for diabetes mellitus.
    Herman WH; Dasbach EJ; Songer TJ; Eastman RC
    Endocrinol Metab Clin North Am; 1997 Sep; 26(3):679-95. PubMed ID: 9314022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depression treatment decreases healthcare expenditures among working age patients with comorbid conditions and type 2 diabetes mellitus along with newly-diagnosed depression.
    Bhattacharya R; Shen C; Wachholtz AB; Dwibedi N; Sambamoorthi U
    BMC Psychiatry; 2016 Jul; 16():247. PubMed ID: 27431801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic aspects of the association between diabetes and depression: a systematic review.
    Molosankwe I; Patel A; José Gagliardino J; Knapp M; McDaid D
    J Affect Disord; 2012 Oct; 142 Suppl():S42-55. PubMed ID: 23062857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of treating hypertension, hyperglycemia, and hyperlipidemia in African Americans and the general population with type 2 diabetes.
    Tasosa J; Schuster R; McAlearney JS
    J Health Care Poor Underserved; 2010 Feb; 21(1):161-76. PubMed ID: 20173262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.